IFNG and chronic myelogenous leukemia, BCR-ABL1 positive: While the fractions of IFN-γ+TetH60+ cells were similar in untreated and FGK45-treated mice, BC-CML MHCII expression was higher in FGK45-treated mice, indicative of greater in vivo IFN-γ exposure.